Discover Immuneering’s latest breakthrough: atebimetinib delivers unprecedented survival rates in first-line pancreatic cancer.
Immuneering Corporation - Special CallCompany ParticipantsBenjamin Zeskind - Co-Founder, President, CEO & DirectorConference Call ...
Researchers from Queen Mary University of London's School of Biological and Behavioral Sciences, using the simple fission ...
The return of UNSC sanctions on Iran and Tehran’s reaction will define the future of Iran’s nuclear programme. But more than ...
Collaborative research by the University of Tokyo and RIKEN Center for Biosystems Dynamics Research has led to the ...
In the book Old Albanian Tales, written by Mitrush Kuteli in 1965, the phrase “I thought I had come to the door of the magjyp ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback